The Journal of thoracic and cardiovascular surgery
-
J. Thorac. Cardiovasc. Surg. · Sep 2022
Priming protects the spinal cord in an experimental aortic occlusion model.
Paraplegia is a devastating complication in aortic aneurysm surgery. Modifying the spinal cord vasculature is a promising method in spinal cord protection. The aim of this study was to assess whether the spinal cord can be primed by occluding thoracic segmental arteries before simulated aneurysm repair in a porcine model. ⋯ Acute priming protects the spinal cord from ischemic injury in an experimental aortic crossclamp model.
-
J. Thorac. Cardiovasc. Surg. · Sep 2022
Sex differences in patients with cardiogenic shock requiring extracorporeal membrane oxygenation.
Our study assesses differences between male and female patients placed on venoarterial extracorporeal membrane oxygenation for cardiogenic shock. ⋯ After adjusting for baseline difference, there was no difference in outcomes between male and female patients despite differing risk profiles for in-hospital mortality.
-
J. Thorac. Cardiovasc. Surg. · Sep 2022
Facility-level national trends in racial disparities of surgical therapy for early-stage lung cancer.
The racial gap in surgical treatment for early-stage non-small cell lung cancer (NSCLC) has been narrowing at the population level, but it is unknown if this trend persists at the facility level. ⋯ Trends in disparities in the use of resection for early-stage NSCLC are not universal across facility groupings. As efforts are made toward addressing racial disparities in surgical care for NSCLC, it will be important to remember that population-level analyses may mask lack of progress in certain facility groups.
-
J. Thorac. Cardiovasc. Surg. · Sep 2022
Impact of donor blood type on outcomes after prolonged allograft ischemic times.
The study objective was to determine the influence of allograft ischemic time on heart transplant outcomes among ABO donor organ types given limited prior reports of its survival impact. ⋯ Compared with non-O donor hearts, transplantation with O donor hearts with ischemic time 4 hours or more leads to worse survival, with higher rates of primary graft dysfunction and chronic rejection. Caution should be practiced when considering donor hearts with the O blood type when anticipating extended cold ischemic times.